We are live on ! Find out more
UOWF

University of Wisconsin Foundation Portfolio holdings

AUM $113M
1-Year Est. Return 23.15%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+23.15%
3 Year Est. Return
+141.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$847K
Cap. Flow
+$3.33M
Cap. Flow %
2.8%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
3
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$11M
2
JANX icon
Janux Therapeutics
JANX
+$8.51M
3
AAPL icon
Apple
AAPL
+$6.99M
4
MSFT icon
Microsoft
MSFT
+$6.51M
5
NVDA icon
NVIDIA
NVDA
+$6.34M

Top Sells

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$15.6M
2
RNAM
Avidity Biosciences
RNAM
+$12.6M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$5.97M
4
DYN icon
Dyne Therapeutics
DYN
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 42.12%
2 Financials 37.24%
3 Healthcare 20.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NU icon
1
Nu Holdings
NU
$66.9B
$24M 20.16%
1,431,951
– –
PDCC
2
Pearl Diver Credit Co
PDCC
$61.5M
$20.3M 17.09%
1,459,021
– –
AAPL icon
3
Apple
AAPL
$4.57T
$17.8M 14.96%
65,442
+26,040
+66% +$6.99M
NVDA icon
4
NVIDIA
NVDA
$5.42T
$16.6M 13.97%
89,106
+34,040
+62% +$6.34M
MSFT icon
5
Microsoft
MSFT
$3.71T
$15.7M 13.19%
32,429
+12,998
+67% +$6.51M
PCVX icon
6
Vaxcyte
PCVX
$8.64B
$11.4M 9.58%
+247,000
New +$11M
DYN icon
7
Dyne Therapeutics
DYN
$4.9B
$8.15M 6.85%
416,750
-101,000
-20% -$1.91M
JANX icon
8
Janux Therapeutics
JANX
$967M
$5M 4.2%
+362,000
New +$8.51M
AKRO
9
DELISTED
Akero Therapeutics
AKRO
– –
-328,504
Closed -$15.6M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-13,007
Closed -$5.97M
RNAM
11
DELISTED
Avidity Biosciences
RNAM
– –
-289,201
Closed -$12.6M

Similar funds

TBNY
Trustco Bank (New York) Albany, New York $113M AUM 34.59% 1-Year Est. Return
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MC
Matters Capital Miami, Florida $113M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
ML
MSRH LLC New York $113M AUM
PC
Parrish Capital Kennesaw, Georgia $112M AUM
SFP
Sherwood Financial Partners Westlake Village, California $113M AUM 13.04% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

University of Wisconsin Foundation's Q4 2025 Portfolio in Review

As of Q4 2025, University of Wisconsin Foundation held 11 positions worth $119M, up 0.72% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Wisconsin Foundation's Q4 2025 filing shows 2 new, 3 increased, 1 reduced and 3 closed positions. Its largest new stake was Vaxcyte: 247,000 shares worth $11.4M. The largest sale was Akero Therapeutics, an estimated $15.6M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • University of Wisconsin Foundation's largest Q4 2025 buy was Vaxcyte: 247,000 shares worth $11.4M.
  • University of Wisconsin Foundation added most to Apple in Q4 2025, an estimated $6.99M increase.
  • University of Wisconsin Foundation's biggest Q4 2025 reduction was Dyne Therapeutics, cutting an estimated $1.91M.
  • University of Wisconsin Foundation fully exited Akero Therapeutics in Q4 2025, selling an estimated $15.6M.
  • University of Wisconsin Foundation's ten largest holdings make up 100% of its $119M portfolio in Q4 2025.
  • University of Wisconsin Foundation opened 2 new positions and closed 3 in Q4 2025.
  • University of Wisconsin Foundation's portfolio value rose 0.72% quarter-over-quarter to $119M.

Based on University of Wisconsin Foundation's 13F filing for Q4 2025, filed 13 Feb 2026.